Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Front Pharmacol
2019 Jul 03;10:748. doi: 10.3389/fphar.2019.00748.
Show Gene links
Show Anatomy links
From Synthetic Fragments of Endogenous Three-Finger Proteins to Potential Drugs.
Kryukova EV
,
Egorova NS
,
Kudryavtsev DS
,
Lebedev DS
,
Spirova EN
,
Zhmak MN
,
Garifulina AI
,
Kasheverov IE
,
Utkin YN
,
Tsetlin VI
.
???displayArticle.abstract???
The proteins of the Ly6 family have a three-finger folding as snake venom α-neurotoxins, targeting nicotinic acetylcholine receptors (nAChRs), and some of them, like mammalian secreted Ly6/uPAR protein (SLURP1) and membrane-attached Ly-6/neurotoxin (Lynx1), also interact with distinct nAChR subtypes. We believed that synthetic fragments of these endogenous proteins might open new ways for drug design because nAChRs are well-known targets for developing analgesics and drugs against neurodegenerative diseases. Since interaction with nAChRs was earlier shown for synthetic fragments of the α-neurotoxin central loop II, we synthesized a 15-membered fragment of human Lynx1, its form with two Cys residues added at the N- and C-termini and forming a disulfide, as well as similar forms of human SLURP1, SLURP2, and of Drosophila sleepless protein (SSS). The IC50 values measured in competition with radioiodinated α-bungarotoxin for binding to the membrane-bound Torpedo californica nAChR were 4.9 and 7.4 µM for Lynx1 and SSS fragments, but over 300 µM for SLURP1 or SLURP2 fragments. The affinity of these compounds for the α7 nAChR in the rat pituitary tumor-derived cell line GH4C1 was different: 13.1 and 147 µM for SSS and Lynx1 fragments, respectively. In competition for the ligand-binding domain of the α9 nAChR subunit, SSS and Lynx1 fragments had IC50 values of about 40 µM, which correlates with the value found for the latter with the rat α9α10 nAChR expressed in the Xenopus oocytes. Thus, the activity of these synthetic peptides against muscle-type and α9α10 nAChRs indicates that they may be useful in design of novel myorelaxants and analgesics.
Figure 1. Loop II fragment selection and design. (A) Loop II amino acid sequences alignment of Ly6 proteins. The respective synthetic peptide fragments of loop II prepared and studied in present work are labeled with numbers from 1 to 7 (see the Results section) and highlighted with the appropriate color. Cys residues added for the stabilization purposes are highlighted grey. (B) Design of artificial disulfide-stabilized loop II mimetics. To achieve hairpin conformation close to native, water-soluble Lynx1 structure (PDB 2L03) has been analyzed, Met28 and Ser44 (in case of peptide 1) or Thr29 and Lys43 (in case of peptide 3) residues were chosen because their radicals are situated on the same side of the beta-sheet. Selected residues were interchanged to Cys residues in loop II mimetic peptides. The same logic was applied to SLURP1 and SLURP2 structures. SSS loop II fragment was designed based on the sequence alignment.
Figure 2. Competition of [125I]-labeled αBgt with Lynx1 peptides and SSS fragment for binding to (A)
Torpedo californica nAChR, (B) human α7 nAChR expressed in the GH4C1 cell line, and (C) ligand-binding domain (LBD) of the human nAChR α9 subunit. IC50 values and 95% confidence interval (CI 95%) for these data are presented in
Table 2
. Each data point represents the mean ± SEM of three to four independent experiments.
Figure 3. Activity of synthetic Ly6 peptides on human and rat α9α10 nAChRs expressed in X. laevis oocytes. (A) Inhibition of ion currents induced by 30 μM acetylcholine by Lynx1 (1) fragment in the rat (▪, solid line) α9α10 nAChRs or by Lynx1 linear fragment (2) in the human (○, dashed line) α9α10 nAChRs. The oocytes were pre-incubated with peptides for 5 min. For Lynx1 (1) the calculated IC50 was 27.00 μM (CI 95% 14.55–41.26 μM), n = 3. For Lynx1 linear fragment (2) the calculated IC50 was 32.30 μM (CI 95% 14.70–70.99 μM), n = 3. (B) Bar graph of 100 μM SSS fragment (5) inhibition of ion currents induced by 25 μM acetylcholine (ACh) in the human α9α10 nAChR. Data are presented as mean ± SEM, n = 3. Paired Student’s t-test, p < 0.05 (black asterisks, normalized current evoked by acetylcholine in the presence of SSS vs normalized current induced by acetylcholine in the absence of SSS).
Figure 4. Bar graph of 50 μM Ly6 fragments of Lynx1 (1), SLURP1 (6), SLURP2 (7), Lynx1 linear (2), and SSS (5) inhibition of ion currents induced by 30 μM ACh in the human α3β2 nAChR expressed in X. laevis oocytes. The current recorded in response to 30 μM ACh application (ACh) is accepted as 1. The current recorded in response to application of acetylcholine in the presence of peptides was compared with the mean between previous and afterwards acetylcholine-induced current. Normalized currents are presented as mean ± SEM, n = 3 [for SLURP2 (7), Lynx1 linear (2), and SSS (5)] or n = 5 [for Lynx1 (1) and SLURP1 (6)]. Ion current values for Lynx1 (1) and SLURP1 (6) are 0.77 ± 0.08 and 0.74 ± 0.08, respectively.
Blanchet,
Ancestral protein resurrection and engineering opportunities of the mamba aminergic toxins.
2017, Pubmed
Blanchet,
Ancestral protein resurrection and engineering opportunities of the mamba aminergic toxins.
2017,
Pubmed
Bourne,
Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.
2005,
Pubmed
Brams,
A structural and mutagenic blueprint for molecular recognition of strychnine and d-tubocurarine by different cys-loop receptors.
2011,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Brzezicki,
Mambalgins, the Venom-origin Peptides as a Potentially Novel Group of Analgesics: Mini Review.
2018,
Pubmed
Chan,
Snake venom toxins: toxicity and medicinal applications.
2016,
Pubmed
Chimienti,
Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda.
2003,
Pubmed
,
Xenbase
Dellisanti,
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.
2007,
Pubmed
Ding,
The efficacy and safety of Batroxobin in combination with anticoagulation on cerebral venous sinus thrombosis.
2018,
Pubmed
Dubovskii,
Cobra cardiotoxins: membrane interactions and pharmacological potential.
2014,
Pubmed
Durek,
Interaction of Synthetic Human SLURP-1 with the Nicotinic Acetylcholine Receptors.
2017,
Pubmed
Dutertre,
Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms.
2017,
Pubmed
Estevão-Costa,
Snake venom components in medicine: From the symbolic rod of Asclepius to tangible medical research and application.
2018,
Pubmed
Falkenstein,
Synthetic peptides derived from the central loop of fasciculin: structural analysis and evaluation as inhibitors of acetylcholinesterase.
1997,
Pubmed
Fuchs,
Cholinergic inhibition of short (outer) hair cells of the chick's cochlea.
1992,
Pubmed
Gong,
Nicotinic acetylcholine receptor α7 subunit is involved in the cobratoxin-induced antinociception in an animal model of neuropathic pain.
2015,
Pubmed
Grishin,
Amino acid sequence of neurotoxin II from Naja naja oxiana venom.
1973,
Pubmed
Hone,
Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.
2018,
Pubmed
Huang,
Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera.
2013,
Pubmed
Hucho,
The acetylcholine receptor as part of a protein complex in receptor-enriched membrane fragments from Torpedo californica electric tissue.
1978,
Pubmed
Ibañez-Tallon,
Tethering toxins and peptide ligands for modulation of neuronal function.
2012,
Pubmed
Karlsson,
Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors.
2000,
Pubmed
Karlsson,
Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps.
1984,
Pubmed
Kini,
Structure, function and evolution of three-finger toxins: mini proteins with multiple targets.
2010,
Pubmed
Kryukova,
Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
2018,
Pubmed
,
Xenbase
Lin,
Efficient expression of acetylcholine-binding protein from Aplysia californica in Bac-to-Bac system.
2014,
Pubmed
Lyukmanova,
Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors.
2013,
Pubmed
Lyukmanova,
Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1) Is a Selective Allosteric Antagonist of α7 Nicotinic Acetylcholine Receptor.
2016,
Pubmed
,
Xenbase
Lyukmanova,
NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1.
2011,
Pubmed
,
Xenbase
Lyukmanova,
Secreted Isoform of Human Lynx1 (SLURP-2): Spatial Structure and Pharmacology of Interactions with Different Types of Acetylcholine Receptors.
2016,
Pubmed
,
Xenbase
Miwa,
lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.
1999,
Pubmed
,
Xenbase
Miwa,
Enhancement in motor learning through genetic manipulation of the Lynx1 gene.
2012,
Pubmed
Munawar,
MOLECULAR MODEL OF CYTOTOXIN-1 FROM NAJA MOSSAMBICA MOSSAMBICA VENOM IN COMPLEX WITH CHYMOTRYPSIN.
2015,
Pubmed
Narumoto,
Effect of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1) on airway epithelial cells.
2013,
Pubmed
Parker,
Deletion of lynx1 reduces the function of α6* nicotinic receptors.
2017,
Pubmed
Perez,
Mal de Meleda: A Focused Review.
2016,
Pubmed
Poh,
A synthetic weak neurotoxin binds with low affinity to Torpedo and chicken alpha7 nicotinic acetylcholine receptors.
2002,
Pubmed
Rey-Suárez,
Mipartoxin-I, a novel three-finger toxin, is the major neurotoxic component in the venom of the redtail coral snake Micrurus mipartitus (Elapidae).
2012,
Pubmed
Rucktooa,
Insight in nAChR subtype selectivity from AChBP crystal structures.
2009,
Pubmed
Sala,
Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.
2018,
Pubmed
Schroeder,
Chemical synthesis, 3D structure, and ASIC binding site of the toxin mambalgin-2.
2014,
Pubmed
Shelukhina,
Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant.
2018,
Pubmed
,
Xenbase
Sixma,
Acetylcholine binding protein (AChBP): a secreted glial protein that provides a high-resolution model for the extracellular domain of pentameric ligand-gated ion channels.
2003,
Pubmed
Smit,
A glia-derived acetylcholine-binding protein that modulates synaptic transmission.
2001,
Pubmed
Swamynathan,
Inhibition of HUVEC tube formation via suppression of NFκB suggests an anti-angiogenic role for SLURP1 in the transparent cornea.
2017,
Pubmed
Thomsen,
Expression of the Ly-6 family proteins Lynx1 and Ly6H in the rat brain is compartmentalized, cell-type specific, and developmentally regulated.
2014,
Pubmed
Tsetlin,
Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: pharmacological tools and endogenous modulators.
2015,
Pubmed
Ulens,
Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.
2006,
Pubmed
Utkin,
Three-finger toxins, a deadly weapon of elapid venom--milestones of discovery.
2013,
Pubmed
Utkin,
"Weak toxin" from Naja kaouthia is a nontoxic antagonist of alpha 7 and muscle-type nicotinic acetylcholine receptors.
2001,
Pubmed
,
Xenbase
Vasilyeva,
Three-Finger Proteins from the Ly6/uPAR Family: Functional Diversity within One Structural Motif.
2017,
Pubmed
Virginio,
Pharmacological properties of rat alpha 7 nicotinic receptors expressed in native and recombinant cell systems.
2002,
Pubmed
Webb,
Soluble Immune Response Suppressor (SIRS): Reassessing the immunosuppressant potential of an elusive peptide.
2016,
Pubmed
Wu,
Structural Analysis and Deletion Mutagenesis Define Regions of QUIVER/SLEEPLESS that Are Responsible for Interactions with Shaker-Type Potassium Channels and Nicotinic Acetylcholine Receptors.
2016,
Pubmed
Wu,
SLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmission.
2014,
Pubmed
Zouridakis,
Crystal structures of free and antagonist-bound states of human α9 nicotinic receptor extracellular domain.
2014,
Pubmed
,
Xenbase
de la Rosa,
Synthetic peptide antigens derived from long-chain alpha-neurotoxins: Immunogenicity effect against elapid venoms.
2017,
Pubmed
